Development and implementation of Drug Use Evaluation (DUE) criteria for risperidone in an outpatient psychiatric setting

Psychopharmacology Bulletin

Volumn 32, Issue 4, 1996, Pages 705-719

  Shepski, John C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

drug use evaluation; drug utilization review; DUE; DUR; risperidone

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; RISPERIDONE;

ADULT; ANXIETY; CONFERENCE PAPER; DEPRESSION; DRUG COST; DRUG USE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MEDICAL STAFF; NEGATIVE SYNDROME; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RESTLESSNESS; SCHIZOIDISM; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREMOR;

ADULT; HUMANS; OUTPATIENTS; RISPERIDONE; SCHIZOPHRENIA;

EID: 0030481784     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Addington, DE; Toews, JA; and Addington, JM. Risperidone and tardive dyskinesia: A case report. J. Clin. Psychiatry 56:484-485, 1995.